Additionally, in a proteomic analysis on effluents from perfused human hearts, the concentration of PGAM2 showed an increasing trend when the ischemic time was extending, suggesting its potential as a diagnostic and therapeutic biomarker for myocardial ischemia 4 .
← all excerpts
Downregulation of PGAM2 alleviates angiotensin II-induced cardiac hypertrophy by destabilizing HSP90 and inactivating the mTOR/IKKα signaling pathway.
1
—
—